Kerstin A Kessel1,2, Evelyn Klein3, Carolin C Hack4, Stephanie E Combs5,6. 1. Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany. kerstin.kessel@tum.de. 2. Institute for Innovative Radiotherapy(iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany. kerstin.kessel@tum.de. 3. Department of Gynecology and Obstetrics, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany. 4. Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen/European Metropolitan Area Nuremberg (CCC ER-EMN), Universitätsstraße 21-23, Erlangen, Germany. 5. Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany. 6. Institute for Innovative Radiotherapy(iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.
Abstract
INTRODUCTION: Recently, complementary and alternative medicine (CAM) has moved more into the focus, and cancer societies such as the German Cancer Society (Deutsche Krebsgesellschaft, DKG) have established working groups to develop a guideline for CAM. The present work aims to evaluate the acceptance of CAM in the whole radiation oncology community. METHODS: We conducted an online survey on CAM and sent the modified questionnaire that was successfully distributed to all members of the Research Group on Gynecological Oncology (Arbeitsgemeinschaft Gynakologische Onkologie, AGO) of the DKG in 2014 to the members of the German Society of Radiation Oncology (Deutsche Gesellschaft für Radioonkologie und Strahlentherapie, DEGRO). The survey consisted of 17 questions regarding personal information and current CAM guidelines within the workplace/clinic. RESULTS: A total of 143 members participated. Of these, 12% had some CAM qualification. For hematological cancer in 35% and in up to 76% for breast cancer, CAM treatment is offered in German radiation oncology facilities, mainly due to fatigue symptoms. CAM is part of routine treatment in 32.2%, 22.0% are planning to incorporate it. Most physicians advise patients to partake in sports activities and recommend dietary supplements and nutritional counseling. The cost of CAM treatment is fully covered in 9.8% of all participating facilities. CONCLUSION: Today, CAM is integrated into cancer care; however, skepticism regarding its effect still exists. Evidence-based results must be generated to convince physicians of the effectiveness of CAM methods. CAM qualifications must be included in physicians' training to improve their understanding and counseling regarding CAM options in cancer care.
INTRODUCTION: Recently, complementary and alternative medicine (CAM) has moved more into the focus, and cancer societies such as the German Cancer Society (Deutsche Krebsgesellschaft, DKG) have established working groups to develop a guideline for CAM. The present work aims to evaluate the acceptance of CAM in the whole radiation oncology community. METHODS: We conducted an online survey on CAM and sent the modified questionnaire that was successfully distributed to all members of the Research Group on Gynecological Oncology (Arbeitsgemeinschaft Gynakologische Onkologie, AGO) of the DKG in 2014 to the members of the German Society of Radiation Oncology (Deutsche Gesellschaft für Radioonkologie und Strahlentherapie, DEGRO). The survey consisted of 17 questions regarding personal information and current CAM guidelines within the workplace/clinic. RESULTS: A total of 143 members participated. Of these, 12% had some CAM qualification. For hematological cancer in 35% and in up to 76% for breast cancer, CAM treatment is offered in German radiation oncology facilities, mainly due to fatigue symptoms. CAM is part of routine treatment in 32.2%, 22.0% are planning to incorporate it. Most physicians advise patients to partake in sports activities and recommend dietary supplements and nutritional counseling. The cost of CAM treatment is fully covered in 9.8% of all participating facilities. CONCLUSION: Today, CAM is integrated into cancer care; however, skepticism regarding its effect still exists. Evidence-based results must be generated to convince physicians of the effectiveness of CAM methods. CAM qualifications must be included in physicians' training to improve their understanding and counseling regarding CAM options in cancer care.
Entities:
Keywords:
Fatigue; Integrative medicine; Neoplasms; Quality of life; Surveys and questionnaires
Authors: J Hübner; K Muenstedt; R Muecke; O Micke; C Stoll; U R Kleeberg; J Buentzel; G Dennert; F J Prott Journal: Strahlenther Onkol Date: 2013-07-05 Impact factor: 3.621
Authors: Serkan Sertel; Saskia Herrmann; Henry Johannes Greten; Volker Haxsen; Samir El-Bitar; Christian Heinrich Simon; Ingo Baumann; Peter Karl Plinkert Journal: Eur Arch Otorhinolaryngol Date: 2008-11-04 Impact factor: 2.503
Authors: Kerstin A Kessel; Sabrina Lettner; Carmen Kessel; Henning Bier; Tilo Biedermann; Helmut Friess; Peter Herrschbach; Jürgen E Gschwend; Bernhard Meyer; Christian Peschel; Roland Schmid; Markus Schwaiger; Klaus-Dietrich Wolff; Stephanie E Combs Journal: PLoS One Date: 2016-11-03 Impact factor: 3.240
Authors: Evelyn Klein; Matthias W Beckmann; Werner Bader; Cosima Brucker; Gustav Dobos; Dorothea Fischer; Volker Hanf; Annette Hasenburg; Sebastian M Jud; Matthias Kalder; Marion Kiechle; Sherko Kümmel; Andreas Müller; Myrjam-Alice T Müller; Daniela Paepke; Andre-Robert Rotmann; Florian Schütz; Anton Scharl; Petra Voiss; Markus Wallwiener; Claudia Witt; Carolin C Hack Journal: Arch Gynecol Obstet Date: 2017-06-08 Impact factor: 2.344
Authors: Trine Stub; Sara A Quandt; Thomas A Arcury; Joanne C Sandberg; Agnete E Kristoffersen Journal: BMC Complement Altern Med Date: 2018-01-31 Impact factor: 3.659
Authors: Pirus Ghadjar; Wiebke Stritter; Irina von Mackensen; Felix Mehrhof; Clara Foucré; Vincent H Ehrhardt; Marcus Beck; Pimrapat Gebert; Goda Kalinauskaite; Jacqueline S Luchte; Carmen Stromberger; Volker Budach; Angelika Eggert; Georg Seifert Journal: Radiat Oncol Date: 2021-04-19 Impact factor: 3.481